c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
暂无分享,去创建一个
[1] S. Shousha,et al. c-erbB-2 expression in different histological types of invasive breast carcinoma. , 1991, Journal of clinical pathology.
[2] D. Weiner,et al. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[3] W. Gullick,et al. NCL‐CB11, a new monoclonal antibody recognizing the internal domain of the c‐erbB‐2 oncogene protein effective for use on formalin‐fixed, paraffin‐embedded tissue , 1990, The Journal of pathology.
[4] S. Ashley,et al. Immunohistochemical distribution of c‐erbB‐2 in in situ breast carcinoma—a detailed morphological analysis , 1990, The Journal of pathology.
[5] B. Gusterson,et al. Rat monoclonal antibodies to the external domain of the product of the C‐erbB‐2 proto‐oncogene , 1990, International journal of cancer.
[6] W. Franklin,et al. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit. , 1990, Molecular and cellular probes.
[7] M. Delmée,et al. Detection of specific antigens for ten serogroups of Clostridium difficile. , 1990, Molecular and cellular probes.
[8] T. Pawson,et al. Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseases. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[9] A. Ullrich,et al. Studies of the HER-2/neu Proto-Oncogene in Human Breast Cancer , 1989 .
[10] B Angus,et al. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. , 1989, Cancer research.
[11] R. Zeillinger,et al. HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. , 1989, Oncogene.
[12] M. J. van de Vijver,et al. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. , 1988, The New England journal of medicine.
[13] D. Altman,et al. An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma. , 1988, British Journal of Cancer.
[14] B. Gusterson,et al. c-erbB-2 expression in benign and malignant breast disease. , 1988, British Journal of Cancer.
[15] David L. Page,et al. Diagnostic Histopathology of the Breast , 1988 .
[16] B. Groner,et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. , 1988, Cancer research.
[17] B. Gusterson,et al. Immunohistochemical localization of c-erbB-2 in human breast carcinomas. , 1987, Molecular and cellular probes.
[18] J. Yokota,et al. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. , 1987, Cancer research.
[19] W. Gullick,et al. OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATION , 1987, The Lancet.
[20] M. J. van de Vijver,et al. Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene , 1987, Molecular and cellular biology.
[21] B. Rasmussen,et al. Prognostic factors in primary mucinous breast carcinoma. , 1987, American journal of clinical pathology.
[22] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[23] Cori Bargmann,et al. The neu oncogene encodes an epidermal growth factor receptor-related protein , 1986, Nature.
[24] J. Yokota,et al. AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO , 1986, The Lancet.
[25] N. Nomura,et al. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor , 1986, Nature.
[26] K. Semba,et al. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Weinberg,et al. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. , 1985, Science.
[28] C R King,et al. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. , 1985, Science.
[29] S. Duffy,et al. Infiltrating lobular carcinoma of the breast: An evaluation of the incidence and consequence of bilateral disease , 1983, The British journal of surgery.
[30] P. Rosen. Tubular carcinoma of the breast. , 1980, The American journal of surgical pathology.
[31] P. Rosen,et al. Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow‐up , 1977, Cancer.
[32] A. Huvos,et al. Infiltrating lobular carcinoma of the breast , 1973, Cancer.